Cited by 105HIV/AIDS Research and InterventionsReproductive tract infections researchSyphilis Diagnosis and Treatment

STD screening of HIV-infected MSM in HIV clinics.

Hoover, Karen W., Butler, Mary, Workowski, Kimberly, Carpio, Felix, Follansbee, Stephen, Gratzer, Beau, Hare, Brad, Johnston, Barbara +7 more·2010·Sexually Transmitted Diseases

Abstract

BACKGROUND: National guidelines for the care of human immunodeficiency virus (HIV)-infected persons recommend asymptomatic routine screening for sexually transmitted diseases (STDs). Our objective was to determine whether providers who care for HIV-infected men who have sex with men (MSM) followed these guidelines. METHODS: We abstracted medical records to evaluate STD screening at 8 large HIV clinics in 6 US cities. We estimated the number of men who had at least one test for syphilis, chlamydia (urethral and/or rectal), or gonorrhea (urethral, rectal, and/or pharyngeal) in 2004, 2005, and 2006. Urethral testing included nucleic acid amplification tests of both urethral swabs and urine. We also calculated the positivity of syphilis, chlamydia, and gonorrhea among screened men. RESULTS: Medical records were abstracted for 1334 HIV-infected MSM who made 14,659 visits from 2004-2006. The annual screening rate for syphilis ranged from 66.0% to 75.8% during 2004-2006. Rectal chlamydia and rectal and pharyngeal gonorrhea annual screening rates ranged from 2.3% to 8.5% despite moderate to high positivity among specimens from asymptomatic patients (3.0%-9.8%) during this period. Annual urethral chlamydia and gonorrhea screening rates were higher than rates for nonurethral sites, but were suboptimal, and ranged from 13.8% to 18.3%. CONCLUSIONS: Most asymptomatic HIV-infected MSM were screened for syphilis, indicating good provider adherence to this screening guideline. Low screening rates for gonorrhea and chlamydia, especially at rectal and pharyngeal sites, suggest that substantial barriers exist for complying with these guidelines. The moderate to high prevalence of asymptomatic chlamydial and gonococcal infections underscores the importance of screening. A range of clinical quality improvement interventions are needed to increase screening, including increasing the awareness of nucleic acid amplification tests for nonurethral screening.

Integrity signals

Registry

Crossref · 10.1097/olq.0b013e3181e50058

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • MSM living with HIV infection and engaged in care also experience suboptimal rates of STI testing.

    “MSM living with HIV infection and engaged in care also experience suboptimal rates of STI testing (222,223).”

    From Sexually Transmitted Infections Treatment Guidelines, 2021 (2021) · cites this paper as [222]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Hoover, K. W., Butler, M., Workowski, K., Carpio, F., Follansbee, S., Gratzer, B., Hare, B., Johnston, B., Theodore, J. L., Wohlfeiler, M., Tao, G., Brooks, J. T., Chorba, T., Irwin, K., & Kent, C. K.
Affiliations
  • Centers for Disease Control and Prevention (US)
  • San Francisco General Hospital (US)
  • Kaiser Permanente (US)
  • Emory University (US)
  • AltaMed (US)
Corresponding author
  • Hoover, Karen W.
  • Workowski, Kimberly
  • Gratzer, Beau
  • Tao, Guoyu
  • Brooks, John T.
  • Chorba, Terence
  • Irwin, Kathleen
  • Kent, Charlotte K.
Venue
Sexually Transmitted Diseases
Published
2010-12
Volume
37
Issue
12
Pages
771-776
ISSN
0148-5717 (ISSN-L)
OpenAlex
W2073115674
Cited by
105
References
31
Citations by year
2026: 1 · 2025: 1 · 2024: 3 · 2023: 1 · 2022: 2 · 2021: 7 · 2020: 14 · 2019: 10 · 2018: 5 · 2017: 9 · 2016: 9 · 2015: 10 · 2014: 14 · 2013: 7 · 2012: 4
FWCI
3.93
Type
journal article
Language
en
Open access
closed
Locations
  • Sexually Transmitted Diseases (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
  • Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
  • Health Sciences › Medicine › Physiology › Syphilis Diagnosis and Treatment
Keywords
STI screening, HIV-infected men who have sex with men, syphilis, chlamydia, gonorrhea, rectal screening, nucleic acid amplification tests, guideline adherence, asymptomatic infection, HIV clinics
MeSH terms
Adult, Aged, Ambulatory Care Facilities, Chlamydia Infections, Gonorrhea, Humans, Male, Mass Screening, Medical Records, Middle Aged, Sexually Transmitted Diseases, Syphilis, United States, HIV Infections, Homosexuality, Male, Guideline Adherence, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review